Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Consultation on HPV self-sampling option for cervical cancer screening in the UK

On December 4, 2024, the UK National Screening Committee (UK NSC) launched a consultation on whether to offer human papillomavirus (HPV) self-sampling option to under-screened people in the cervical cancer screening program alongside traditional clinician-collected sampling by a nurse or doctor. 

The following new recommendation is proposed by the UK NSC:

  • Self-sampling for HPV testing should be offered to under-screened people eligible for the NHS Cervical Screening Programme in the 4 UK countries, where service commissioners think self-sampling would be a helpful addition to the program.

Any individual or organization can participate in the consultation and provide their views on:

  • Self-sampling in under-screened people as a strategy to improve participation in cervical screening;
  • The quality and accuracy of the supporting documents and evidence;
  • Whether the recommendation is consistent with the evidence presented;
  • The feasibility of the recommendation.

The deadline for comments submission is February 26, 2025. 

See the full details here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.